Research Article

An Examination of the Regulatory Regime for Stem Cell Technology in Nigeria: Challenges and Prospects

1 Faculty of Law, University of Abuja
2 Legal Practitioner & Principal Attorney at M.C. Sojachukwu & Co
* Corresponding author: jonathan.jiyah@uniabuja.edu.ng
Published: Sep, 2025
Pages: 330–355

Abstract

Stem cell technology offers hope and treatment for a wide range of diseases by replacing damaged cells with new ones derived from stem cells. Recent years have witnessed exponential advancements in clinical trials revolving around stem cell-based therapies. Stem cell technology holds enormous potentials for regenerative medicine. However, harnessing the potentials is bedevilled with challenges. A major limitation to the advancement stem cell technology in Nigeria is insufficient regulatory framework. The controversy surrounding stem cell technology stems primarily from ethical, medical, legal and political concerns. The sourcing of stem cells constitutes a major challenge regarding their use in animals and humans. Religious and traditional beliefs constitute a great hindrance to the application of stem cell technology in Nigeria. Other challenges include inadequate investment in stem cell technology, commercialization of access to therapeutic care, lack of awareness and inconsistent power supply. This paper examines the regulatory regime for stem cell technology in Nigeria and discusses the challenges and prospects. The methodology employed is the doctrinal approach; which focuses on the letter of the law rather than the law in action. In view of the growing need for stem cells for therapeutic uses globally, it has become imperative to fix these challenges.
How to Cite

NDANA, J., & SOJACHUKWU, M. (2025). An Examination of the Regulatory Regime for Stem Cell Technology in Nigeria: Challenges and Prospects. ABU Law Journal, 43(2), 330–355.

J. NDANA, and M. SOJACHUKWU, "An Examination of the Regulatory Regime for Stem Cell Technology in Nigeria: Challenges and Prospects," ABU Law Journal, vol. 43, no. 2, pp. 330–355, September 2025.

Share this article:
Facebook X / Twitter LinkedIn